<ENAMEX TYPE="ORGANIZATION">G D Searle Co</ENAMEX> said the Food and <ENAMEX TYPE="ORGANIZATION">Drug Administration</ENAMEX> approved the sale of <ENAMEX TYPE="ORGANIZATION">Kerlone</ENAMEX> a hypertension drug developed by a joint venture between <ENAMEX TYPE="ORGANIZATION">Searle</ENAMEX> and a French concern <ENAMEX TYPE="ORGANIZATION">Searle</ENAMEX> a unit of <ENAMEX TYPE="ORGANIZATION">Monsanto Co</ENAMEX> said the beta blocker high blood pressure drug <ENAMEX TYPE="ORGANIZATION">Kerlone</ENAMEX> is the first product to reach the market through <ENAMEX TYPE="ORGANIZATION">Lorex Pharmaceuticals</ENAMEX> the U S company jointly owned by <ENAMEX TYPE="ORGANIZATION">Searle</ENAMEX> and <ENAMEX TYPE="PERSON">Synthelabo</ENAMEX> a French pharmaceutical concern owned by <ENAMEX TYPE="LOCATION">France</ENAMEX> s L Oreal S <ENAMEX TYPE='untagged'>A</ENAMEX>